Alpha1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis

BACKGROUND: Fecal alpha-1-antitrypsin (AAT) clearance has been a marker of clinical disease severity in inflammatory bowel diseases (IBD) for many years. While AAT deficiency is more often associated with lung and liver pathologies, AAT-deficient patients with concomitant IBD have been shown to deve...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Inflamm Bowel Dis
Autors principals: Collins, Colm B., Aherne, Carol M., Ehrentraut, Stefan F., Gerich, Mark E., McNamee, Eóin N., McManus, Martine C., Lebsack, Matthew D.P., Jedlicka, Paul, Azam, Tania, de Zoeten, Edwin F., Dinarello, Charles A., Rivera-Nieves, Jesús
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654462/
https://ncbi.nlm.nih.gov/pubmed/23835442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0b013e31829292aa
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars